Christophe Legendre
Hôpital Necker-Enfants Malades(FR)Inserm(FR)Université Paris Cité(FR)Institut Necker Enfants Malades(FR)Sorbonne Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)
Publications by Year
Research Areas
Renal Transplantation Outcomes and Treatments, Renal Diseases and Glomerulopathies, Organ Transplantation Techniques and Outcomes, Organ Donation and Transplantation, Complement system in diseases
Most-Cited Works
- → Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome(2013)1,539 cited
- → Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival(2013)824 cited
- → Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation(1999)715 cited
- → The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology(2016)615 cited
- → Targeted therapy in patients with PIK3CA-related overgrowth syndrome(2018)557 cited
- → Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies(2015)412 cited